MarketInOut Stock Screener Log In | Sign Up
 

Quest PharmaTech Inc

TSXV • Healthcare • Biotechnology • Quote as of 08/27/2026
Quest PharmaTech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSXV
Market Capitalization4.23 mln
Float139 mln
Earnings Date09/27/2026

EPS

0.03
Marginal

P / E

0.67
Anomalous

Piotroski F-Score

4 / 9
Borderline

Relative Strength

36 / 100
Underperforming

Debt / Equity

0.04
Debt-free

ROE

21.75
Strong

Business Description

Quest PharmaTech is a Canadian company based in Edmonton, Alberta, focused on finding better ways to treat cancer. Its most advanced project involves a drug called MAb AR9.6, which is being studied as a potential treatment and diagnostic tool for pancreatic cancer. The drug is currently in early-stage laboratory testing.

Key Fundamentals

EPS0.03
P/E0.67
ROE21.75
ROIC-2.84
ROA20.67
EBITDA, mln5.02
EV / EBITDA1.04
EV / EBIT1.04

Financial Strength

Piotroski F-Score 4 / 9
Price to Intrinsic Value0.25
Price to Graham Number0.13
Shiller PE Ratio1.18
Short Ratio0.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 40 / 100   
1 Month -33.33% 1 / 100   
2 Months -33.33% 10 / 100   
6 Months -50% 8 / 100   
1 Year -20% 25 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us